Fri 07 February 2025:
President Cyril Ramaphosa has expressed concern at the potential impact of the decision by the United States government to suspend some of its funding for HIV and Tuberculosis (TB) programmes in African countries for 90 days.
“This funding accounts for about 17% of our country’s HIV spend. We have been able to provide funding from our fiscus for our HIV and TB programmes over the years,” the President said on Thursday, in Cape Town.
Delivering the State of the Nation Address (SONA) on Thursday, the President said government was looking at various interventions to address the immediate needs and ensure the continuity of essential services.
__________________________________________________________________________
https://whatsapp.com/channel/0029VaAtNxX8fewmiFmN7N22
__________________________________________________________________________
The review of the grant funding programmes affects the US President’s Emergency Plan for AIDS Relief (PEPFAR) programme, which is aimed at supporting HIV prevention, care and treatment. The programme supports several countries, including South Africa, to achieve HIV epidemic control.
“We are encouraged by the great progress the country has made towards ending HIV and AIDS as a public health threat.
“By the end of March 2024, 96 percent of people living with HIV knew their status, 79 percent of these were on antiretroviral treatment and 94 percent of those on treatment were virally suppressed.
“To ensure that we reach our target of 95-95-95, we will this year launch a massive campaign to look for an additional 1.1 million people who are not on treatment,” the President said.
– SAnews.gov.za
__________________________________________________________________________
FOLLOW INDEPENDENT PRESS:
WhatsApp CHANNEL
https://whatsapp.com/channel/0029VaAtNxX8fewmiFmN7N22
TWITTER (CLICK HERE)
https://twitter.com/IpIndependent
FACEBOOK (CLICK HERE)
https://web.facebook.com/ipindependent
YOUTUBE (CLICK HERE)
https://www.youtube.com/@ipindependent
Think your friends would be interested? Share this story!